between accident and end-stage osteoarthritis (arthrodesis or prosthesis) of 1–52 years ( 4 ). Because of this confusing lack of clear and recent evidence for the prognosis of ankle fractures, we performed a systematic review addressing the following
2 , 3
During recent decades advances in the diagnosis, management and prognosis of patients with bone tumours around the elbow have been made. Early diagnosis and preoperative planning is essential and can dramatically change the treatment
circumstances, notable clinical signs and radiographic evidence.
In up to 79% of cases, the diagnosis is made only once the injury has become chronic and the shoulder has been locked, which unfortunately has a negative effect on prognosis. McLaughlin
prognostic factors for an ankle sprain could help clinicians identify patients with a poor prognosis and choose the right treatment. Conversely, identifying patients with a good prognosis could have benefits for healthcare, health cost and resource use. Many
Olga SavvidouFirst Department of Orthopaedic Surgery, National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece These authors contributed equally to this manuscript
Olympia PapakonstantinouSecond Department of Radiology, National and Kapodistrian University of Athens, Medical School, Attikon University General Hospital, Athens, Greece These authors contributed equally to this manuscript
features, the current treatment and the prognosis of juxtacortical bone tumours.
Surface osteosarcomas are distinct clinicopathological entities of osteogenic tumours rather than a subtype of intramedullary conventional
-preservation procedure, the prognosis for patients with ONFH can be significantly improved with early diagnosis and intervention.
3 , 14
Many variables, such as stage of the disease, patient age, lesion size, and lesion location, play an important role in selection
cartilage in patients at risk of developing or with mild OA ( 99 ), and elderly individuals and advanced OA patients are similarly expected to improve disease prognosis and function ( 98 ). In addition, preoperative NEMEX can effectively relieve
) Classification of Tumors of Soft Tissue and Bone now separates chondrosarcoma into two International Classification of Diseases codes. This is reflective of the different prognosis of chondrosarcoma based on grade, with Grade I distinguished from Grade II and
the patient’s prognosis.
1 - 5
Therefore, decisions regarding treatments are usually based on the extent of the disease and evidence of critical organ (risk organ) dysfunction. Risk organs for LCH include the lungs, liver, spleen and bone marrow
amputation after multidisciplinary team discussions.
7 - 9
The prognosis of foot malignancy is not different from that at other location, except perhaps in chondrosarcoma, which seems to be less aggressive in the foot.
The anatomy of the foot is